glp-1 gestational diabetes receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://t.co/AK53R8UJ1V Unveiling Gestational Diabetes: An Overview

Ajnlhat mindazok szmra, akik a mindennapok sorn sok energit hasznlnak fel, sportolnak, nehz fizikai munkt vgeznek, s szeretnk trendjket kiegszteni

A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)

Obesity is a long-term, chronic condition, and just like other chronic health issues, it often requires ongoing support

Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Krankel N, Kania G, Zewinger S, Akhmedov A, Shi Y, Martin T, Perisa D, Winnik S, Muller MF, Sester U, Wernicke G, Jung A, Gutteck U, Eriksson U, Geisel J, Deanfield J, von Eckardstein A, Luscher TF, Fliser D, Bahlmann FH, Landmesser U